MoneyWorks4Me

Ind-Ra assigns Shilpa Medicare’s long term rating at ‘A+’

16 Dec 2020 Evaluate

Credit rating agency-- India Ratings and Research (Ind-Ra) has assigned rating to Shilpa Medicare’s long term rating at ‘A+/Stable’ and short term rating at ‘A+/Stable/A1’ against the existing ratings of long term rating of ‘A (Stable)’ and short term rating of ‘A1’ assigned by ICRA.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..